Reaggregated Beta Cell Clusters for Glucose-Responsive Islet Function
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The shortage of pancreatic islet donors hinders the effective implementation of pancreatic islet transplantation for treating diabetes, and there is a need for methods to recreate pancreatic islets with functional characteristics similar to endogenous islets in vitro.
Innovation Solution
The development of an in vitro cell cluster comprising non-native pancreatic β cells with specific marker expressions (NKX6.1+, C-peptide+, chromogranin A+, and low SOX2/SOX9+) and a method involving differentiation, dissociation, and reaggregation in a defined culture medium to form clusters with enhanced insulin secretion response.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pancreatic islet transplantation is performed to treat diabetes, then the function of insulin secretion is restored, but the shortage of pancreatic islet donors limits the effectiveness of this therapy
Solution Approach 1:
The patent creates in vitro cell clusters that copy the structure and function of native pancreatic islets. These clusters are composed of pancreatic beta cells derived from stem cells, which replicate the insulin secretion capabilities of endogenous islets without requiring donor pancreases. The cell clusters are formed by aggregating differentiated beta cells in a three-dimensional structure that mimics native islet architecture, enabling them to function as artificial pancreatic islets for diabetes treatment
Solution Approach 2:
The patent employs parameter changes in the differentiation and aggregation process of stem cells to generate functional beta cells. By controlling culture conditions, growth factors, and temporal parameters during cell differentiation, the patent transforms pluripotent stem cells into mature beta cells with appropriate functional characteristics. The reaggregation process also utilizes parameter optimization to enhance cell-cluster formation and functional maturation
2Quantity of substance
If artificial pancreatic islets are created in vitro to address donor shortage, then the availability of transplantable material increases, but the functional characteristics must be maintained to ensure therapeutic effectiveness
Solution Approach 1:
The patent performs preliminary differentiation of stem cells into pancreatic progenitor cells and then into beta cells before aggregation. This staged approach ensures that cells are properly matured and equipped with the necessary functional machinery (insulin synthesis, glucose sensing, secretion apparatus) before being assembled into clusters. The preliminary characterization of cell clusters for beta cell identity and function is also performed to ensure quality before transplantation
Solution Approach 2:
The patent implements feedback mechanisms through characterization assays that measure beta cell identity markers and functional parameters. These assays provide information about the quality and maturity of differentiated cells and formed clusters, allowing optimization of differentiation protocols and aggregation conditions to maintain high functional standards in the produced cell clusters
Data Source
AI summary
The present application discloses cell clusters resembling the function and characteristics of endogenous pancreatic islets, and methods for making and using such cell clusters.